Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
| ▸ | PGGT1B | P53609 | 8/20 | 0.34 |
| ▸ | FNTA | P49354 | 7/20 | 0.34 |
| ▸ | FNTB | P49356 | 7/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | FAP | Q12884 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7128883 | 0.85 | HRH3 (0.34) | GPR119PGGT1BFNTAFNTBHRH3 | |
| SCHEMBL7593385 | 0.83 | FNTA (0.38) | GPR119PGGT1BFNTAFNTBHRH3 | |
| SCHEMBL7130693 | 0.81 | DPP4 (0.38) | HRH3DPP4FAPDPP8DPP9 | |
| SCHEMBL7593432 | 0.81 | FNTA (0.36) | GPR119PGGT1BFNTAFNTBHRH3 | |
| SCHEMBL7128886 | 0.81 | FNTA (0.36) | GPR119PGGT1BFNTAFNTBHRH3 | |
| SCHEMBL7593498 | 0.81 | FNTA (0.36) | GPR119PGGT1BFNTAFNTBHRH3 | |
| SCHEMBL7118951 | 0.81 | FNTA (0.36) | GPR119PGGT1BFNTAFNTBHRH3 | |
| SCHEMBL7127275 | 0.81 | FNTA (0.36) | GPR119PGGT1BFNTAFNTBHRH3 | |
| SCHEMBL7592792 | 0.81 | HRH1 (0.41) | GPR119P2RX7PGGT1BFNTAFNTB | |
| SCHEMBL7716788 | 0.80 | DPP4 (0.36) | HRH3DPP4FAPDPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020072081-A1 | Geranylgeranyl transferase inhibitor screening assay | ENG WAI-SI (US) | 2002-06-13 | — | — | US | claimed |
| US-20020072081-A1 | Geranylgeranyl transferase inhibitor screening assay | ENG WAI-SI (US) | 2002-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020072081-A1 | Geranylgeranyl transferase inhibitor screening assay | GGT1, FNTA, GGPS1 | GPR119 2391/4885P2RX7 4688/4885PGGT1B 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.